SCHEMBL9118424

SCHEMBL9118424

CC(C)CCN1CC[C@H]2c3cccc(O)c3CC[C@H]21

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 9/20 0.76
HTR1A P08908 8/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9118429 1.00 DRD2 (0.76) DRD2HTR1A
SCHEMBL9119258 0.86 HTR1A (1.00) DRD2HTR1A
SCHEMBL9119265 0.86 HTR1A (1.00) DRD2HTR1A
Hydrochloric Acid SCHEMBL9441254 0.85 HTR1A (0.97) DRD2HTR1A
Hydrochloric Acid SCHEMBL9120284 0.85 HTR1A (0.97) DRD2HTR1A
SCHEMBL9119868 0.83 HTR1A (0.77) DRD2HTR1A
SCHEMBL9119857 0.83 HTR1A (0.77) DRD2HTR1A
SCHEMBL9121595 0.81 DRD2 (0.72) DRD2HTR1A
Hydrochloric Acid SCHEMBL9118145 0.81 DRD2 (0.72) DRD2HTR1A
Hydrochloric Acid SCHEMBL9441271 0.81 DRD2 (0.72) DRD2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0548664-B1 2,3,3a-5,9b-hexahydro-1H-benzo(e)indole derivatives HOFFMANN LA ROCHE (CH) 1995-05-31 EP disclosed
US-5318966-A Administering the enzyme inhibitor for treating alzheimer's disease, learning enhancement, brain disorders HOFFMANN-LA ROCHE INC. (US) 1994-06-07 US disclosed
US-5318967-A Cognition activators for alzheimer's disease, learning enhancement HOFFMANN-LA ROCHE INC. (US) 1994-06-07 US disclosed
EP-0548664-A1 2,3,3a-5,9b-hexahydro-1H-benzo(e)indole derivatives F. HOFFMANN-LA ROCHE AG (CH) 1993-06-30 EP disclosed